Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine portfolio and will be responsible for advancing the company’s emerging pipeline of cardiovascular, metabolic, hematologic, and obesity medicines. Most recently, Dr. List served as Senior Vice President, Global Therapeutic Area Head for Cardiovascular and Metabolism at Janssen.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Target reports Q4 beat, Walgreens reportedly near go-private deal: Morning Buzz
- Pfizer could use existing U.S. production to counter tariff hit, Reuters reports
- HHS increasing scrutiny of vaccines under RFK Jr., WSJ reports
- Pfizer comments on Q1, Q2 numbers amid higher rebate expense
- Salesforce CEO Benioff says ‘this was the best quarter we ever had’